Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea

Hye-Young Kang, Ki Hwan Kim, Ji Hong Kim, Hwang Min Kim, Jinkyung Kim, Mi Sun Kim, Antoine C. El Khoury, Dong Soo Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The authors assessed the cost-effectiveness of rotavirus vaccination to develop an evidence-based national immunization program in Korea. A Markov model was constructed to compare the costs and clinical outcomes of vaccination versus no vaccination. The birth cohort of 493189 infants in 2007 was followed until the age of 5 years. Korea-specific data for epidemiological characteristics and economic burden of rotavirus diarrhea were used for the modeled estimation. Efficacy of RotaTeq® was based on a recent clinical trial. Rotavirus vaccination would prevent 181238 symptomatic cases (reduction rate = 63.2%) over 5 years after birth. From the societal perspective, at a vaccination cost of 100000 Korean won (KW; 1 US$ ≈ 1200 KW) per dose, universal vaccination would cost 375 620 KW per case averted. The breakeven price of vaccine was 56061 KW. Rotavirus vaccination would reduce the burden of the disease substantially and be a cost-effective strategy to prevent rotavirus diarrhea in Korea.

Original languageEnglish
Pages (from-to)145-158
Number of pages14
JournalAsia-Pacific Journal of Public Health
Volume25
Issue number2
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Immunization Programs
Rotavirus
Korea
Cost-Benefit Analysis
Vaccination
Costs and Cost Analysis
Diarrhea
Parturition
Vaccines
Economics
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Kang, Hye-Young ; Kim, Ki Hwan ; Kim, Ji Hong ; Kim, Hwang Min ; Kim, Jinkyung ; Kim, Mi Sun ; El Khoury, Antoine C. ; Kim, Dong Soo. / Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea. In: Asia-Pacific Journal of Public Health. 2013 ; Vol. 25, No. 2. pp. 145-158.
@article{c2f9e41b30a24d7fb03026abf9f70b2f,
title = "Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea",
abstract = "The authors assessed the cost-effectiveness of rotavirus vaccination to develop an evidence-based national immunization program in Korea. A Markov model was constructed to compare the costs and clinical outcomes of vaccination versus no vaccination. The birth cohort of 493189 infants in 2007 was followed until the age of 5 years. Korea-specific data for epidemiological characteristics and economic burden of rotavirus diarrhea were used for the modeled estimation. Efficacy of RotaTeq{\circledR} was based on a recent clinical trial. Rotavirus vaccination would prevent 181238 symptomatic cases (reduction rate = 63.2{\%}) over 5 years after birth. From the societal perspective, at a vaccination cost of 100000 Korean won (KW; 1 US$ ≈ 1200 KW) per dose, universal vaccination would cost 375 620 KW per case averted. The breakeven price of vaccine was 56061 KW. Rotavirus vaccination would reduce the burden of the disease substantially and be a cost-effective strategy to prevent rotavirus diarrhea in Korea.",
author = "Hye-Young Kang and Kim, {Ki Hwan} and Kim, {Ji Hong} and Kim, {Hwang Min} and Jinkyung Kim and Kim, {Mi Sun} and {El Khoury}, {Antoine C.} and Kim, {Dong Soo}",
year = "2013",
month = "3",
day = "1",
doi = "10.1177/1010539511416806",
language = "English",
volume = "25",
pages = "145--158",
journal = "Asia-Pacific Journal of Public Health",
issn = "1010-5395",
publisher = "SAGE Publications Inc.",
number = "2",

}

Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea. / Kang, Hye-Young; Kim, Ki Hwan; Kim, Ji Hong; Kim, Hwang Min; Kim, Jinkyung; Kim, Mi Sun; El Khoury, Antoine C.; Kim, Dong Soo.

In: Asia-Pacific Journal of Public Health, Vol. 25, No. 2, 01.03.2013, p. 145-158.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea

AU - Kang, Hye-Young

AU - Kim, Ki Hwan

AU - Kim, Ji Hong

AU - Kim, Hwang Min

AU - Kim, Jinkyung

AU - Kim, Mi Sun

AU - El Khoury, Antoine C.

AU - Kim, Dong Soo

PY - 2013/3/1

Y1 - 2013/3/1

N2 - The authors assessed the cost-effectiveness of rotavirus vaccination to develop an evidence-based national immunization program in Korea. A Markov model was constructed to compare the costs and clinical outcomes of vaccination versus no vaccination. The birth cohort of 493189 infants in 2007 was followed until the age of 5 years. Korea-specific data for epidemiological characteristics and economic burden of rotavirus diarrhea were used for the modeled estimation. Efficacy of RotaTeq® was based on a recent clinical trial. Rotavirus vaccination would prevent 181238 symptomatic cases (reduction rate = 63.2%) over 5 years after birth. From the societal perspective, at a vaccination cost of 100000 Korean won (KW; 1 US$ ≈ 1200 KW) per dose, universal vaccination would cost 375 620 KW per case averted. The breakeven price of vaccine was 56061 KW. Rotavirus vaccination would reduce the burden of the disease substantially and be a cost-effective strategy to prevent rotavirus diarrhea in Korea.

AB - The authors assessed the cost-effectiveness of rotavirus vaccination to develop an evidence-based national immunization program in Korea. A Markov model was constructed to compare the costs and clinical outcomes of vaccination versus no vaccination. The birth cohort of 493189 infants in 2007 was followed until the age of 5 years. Korea-specific data for epidemiological characteristics and economic burden of rotavirus diarrhea were used for the modeled estimation. Efficacy of RotaTeq® was based on a recent clinical trial. Rotavirus vaccination would prevent 181238 symptomatic cases (reduction rate = 63.2%) over 5 years after birth. From the societal perspective, at a vaccination cost of 100000 Korean won (KW; 1 US$ ≈ 1200 KW) per dose, universal vaccination would cost 375 620 KW per case averted. The breakeven price of vaccine was 56061 KW. Rotavirus vaccination would reduce the burden of the disease substantially and be a cost-effective strategy to prevent rotavirus diarrhea in Korea.

UR - http://www.scopus.com/inward/record.url?scp=84874896759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874896759&partnerID=8YFLogxK

U2 - 10.1177/1010539511416806

DO - 10.1177/1010539511416806

M3 - Article

C2 - 22234827

AN - SCOPUS:84874896759

VL - 25

SP - 145

EP - 158

JO - Asia-Pacific Journal of Public Health

JF - Asia-Pacific Journal of Public Health

SN - 1010-5395

IS - 2

ER -